{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:43:58Z","timestamp":1783529038710,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"This work was supported by the Algerian Minister of Higher Education and Scientific Research and the training-University Research Project Management Platform","award":["PRFU B00L02UN130120230003"],"award-info":[{"award-number":["PRFU B00L02UN130120230003"]}]},{"name":"This work was supported by the Algerian Minister of Higher Education and Scientific Research and the training-University Research Project Management Platform","award":["PRFU B00L02UN130120230003"],"award-info":[{"award-number":["PRFU B00L02UN130120230003"]}]},{"name":"This work was supported by the Algerian Minister of Higher Education and Scientific Research and the training-University Research Project Management Platform","award":["PRFU B00L02UN130120230003"],"award-info":[{"award-number":["PRFU B00L02UN130120230003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s10735-024-10333-y","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T07:27:23Z","timestamp":1734766043000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exploration of plasma tryptophan levels along with Ki-67 expression binomial investigation for forecasting tumor aggressiveness within invasive ductal breast cancer"],"prefix":"10.1007","volume":"56","author":[{"given":"Takwa","family":"Salmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djilali","family":"Ameur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majda","family":"Dali-Sahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Dib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawel","family":"Amraoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssouf","family":"Kachekouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouria","family":"Dennouni-Medjati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,21]]},"reference":[{"issue":"11","key":"10333_CR1","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1158\/2326-6066.CIR-23-0045","volume":"11","author":"O Adewunmi","year":"2023","unstructured":"Adewunmi O, Shen Y, Zhang XH-F, Rosen JM (2023) Targeted inhibition of lncRNA Malat1 alters the tumor immune microenvironment in preclinical syngeneic mouse models of triple-negative breast cancer. Cancer Immunol Res 11(11):1462\u20131479. https:\/\/doi.org\/10.1158\/2326-6066.CIR-23-0045","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"10333_CR2","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/j.1469-7610.1987.tb00677.x","volume":"28","author":"GM Anderson","year":"1987","unstructured":"Anderson GM, Freedman DX, Cohen DJ et al (1987) Whole blood serotonin in autistic and normal subjects. J Child Psychol Psychiatry 28(6):885\u2013900. https:\/\/doi.org\/10.1111\/j.1469-7610.1987.tb00677.x","journal-title":"J Child Psychol Psychiatry"},{"key":"10333_CR3","doi-asserted-by":"publisher","first-page":"789174","DOI":"10.1155\/2012\/789174","volume":"2012","author":"B Arcidiacono","year":"2012","unstructured":"Arcidiacono B, Iiritano S, Nocera A et al (2012) Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp Diabetes Res 2012:789174. https:\/\/doi.org\/10.1155\/2012\/789174","journal-title":"Exp Diabetes Res"},{"issue":"11","key":"10333_CR4","doi-asserted-by":"publisher","first-page":"BSR20221682","DOI":"10.1042\/BSR20221682","volume":"42","author":"AA-B Badawy","year":"2022","unstructured":"Badawy AA-B (2022) Tryptophan metabolism and disposition in cancer biology and immunotherapy. Biosci Rep 42(11):BSR20221682. https:\/\/doi.org\/10.1042\/BSR20221682","journal-title":"Biosci Rep"},{"issue":"6","key":"10333_CR5","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10333_CR6","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/jnc.13496","volume":"136","author":"J de Bie","year":"2016","unstructured":"de Bie J, Guest J, Guillemin GJ et al (2016) Central kynurenine pathway shift with age in women. J Neurochem 136(5):995\u20131003. https:\/\/doi.org\/10.1111\/jnc.13496","journal-title":"J Neurochem"},{"key":"10333_CR7","doi-asserted-by":"publisher","DOI":"10.1080\/00365513.2018.1542541","author":"DT Eniu","year":"2019","unstructured":"Eniu DT, Romanciuc F, Moraru C et al (2019) The decrease of some serum free amino acids can predict breast cancer diagnosis and progression. Scand J Clin Lab Investig. https:\/\/doi.org\/10.1080\/00365513.2018.1542541","journal-title":"Scand J Clin Lab Investig"},{"issue":"10","key":"10333_CR8","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1002\/oby.21199","volume":"23","author":"M Favennec","year":"2015","unstructured":"Favennec M, Hennart B, Caiazzo R et al (2015) The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation. Obesity 23(10):2066\u20132074. https:\/\/doi.org\/10.1002\/oby.21199","journal-title":"Obesity"},{"issue":"18","key":"10333_CR9","doi-asserted-by":"publisher","first-page":"4544","DOI":"10.3390\/cancers13184544","volume":"13","author":"N G\u00f3mez-Cebri\u00e1n","year":"2021","unstructured":"G\u00f3mez-Cebri\u00e1n N, Domingo-Ort\u00ed I, Poveda JL et al (2021) Multi-omic approaches to breast cancer metabolic phenotyping: applications in diagnosis, prognosis, and the development of novel treatments. Cancers 13(18):4544. https:\/\/doi.org\/10.3390\/cancers13184544","journal-title":"Cancers"},{"issue":"11","key":"10333_CR10","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.3390\/cancers14112793","volume":"14","author":"R Gouasmi","year":"2022","unstructured":"Gouasmi R, Ferraro-Peyret C, Nancey S et al (2022) The Kynurenine pathway and cancer: why keep it simple when you can make it complicated. Cancers 14(11):2793. https:\/\/doi.org\/10.3390\/cancers14112793","journal-title":"Cancers"},{"issue":"1","key":"10333_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1158\/1541-7786.MCR-18-0362","volume":"17","author":"LI Greene","year":"2019","unstructured":"Greene LI, Bruno TC, Christenson JL et al (2019) A role for tryptophan-2,3-dioxygenase in CD8 T-cell suppression and evidence of tryptophan catabolism in breast cancer patient plasma. Mol Cancer Res 17(1):131\u2013139. https:\/\/doi.org\/10.1158\/1541-7786.MCR-18-0362","journal-title":"Mol Cancer Res"},{"issue":"7","key":"10333_CR12","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.nucmedbio.2012.01.010","volume":"39","author":"C Juh\u00e1sz","year":"2012","unstructured":"Juh\u00e1sz C, Nahleh Z, Zitron I et al (2012) Tryptophan metabolism in breast cancers: molecular imaging and immunohistochemistry studies. Nucl Med Biol 39(7):926\u2013932. https:\/\/doi.org\/10.1016\/j.nucmedbio.2012.01.010","journal-title":"Nucl Med Biol"},{"key":"10333_CR13","doi-asserted-by":"publisher","first-page":"852718","DOI":"10.3389\/fonc.2022.852718","volume":"12","author":"R Li","year":"2022","unstructured":"Li R, Wang X, Zhang Y et al (2022) Analysis of tryptophan and its main metabolite kynurenine and the risk of multiple cancers based on the bidirectional mendelian randomization analysis. Front Oncol 12:852718. https:\/\/doi.org\/10.3389\/fonc.2022.852718","journal-title":"Front Oncol"},{"key":"10333_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.biochi.2021.01.005","volume":"182","author":"XH Liu","year":"2021","unstructured":"Liu XH, Zhai XY (2021) Role of tryptophan metabolism in cancers and therapeutic implications. Biochimie 182:131\u2013139. https:\/\/doi.org\/10.1016\/j.biochi.2021.01.005","journal-title":"Biochimie"},{"key":"10333_CR15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1756-0500-4-156","volume":"4","author":"DE Lyon","year":"2011","unstructured":"Lyon DE, Walter JM, Starkweather AR et al (2011) Tryptophan degradation in women with breast cancer: a pilot study. BMC Res Notes 4:156. https:\/\/doi.org\/10.1186\/1756-0500-4-156","journal-title":"BMC Res Notes"},{"key":"10333_CR16","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.3389\/fimmu.2020.01861","volume":"11","author":"LMF Merlo","year":"2020","unstructured":"Merlo LMF, DuHadaway JB, Montgomery JD et al (2020) Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses. Front Immunol 11:1861. https:\/\/doi.org\/10.3389\/fimmu.2020.01861","journal-title":"Front Immunol"},{"key":"10333_CR17","doi-asserted-by":"publisher","first-page":"115015","DOI":"10.1016\/j.biopha.2023.115015","volume":"164","author":"M Nigam","year":"2023","unstructured":"Nigam M, Mishra AP, Deb VK et al (2023) Evaluation of the association of chronic inflammation and cancer: Insights and implications. Biomed Pharmacother 164:115015. https:\/\/doi.org\/10.1016\/j.biopha.2023.115015","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"10333_CR18","doi-asserted-by":"publisher","first-page":"7076","DOI":"10.3390\/ijms24087076","volume":"24","author":"N Niu","year":"2023","unstructured":"Niu N, Ye J, Hu Z et al (2023) Regulative roles of metabolic plasticity caused by mitochondrial oxidative phosphorylation and glycolysis on the initiation and progression of tumorigenesis. Int J Mol Sci 24(8):7076. https:\/\/doi.org\/10.3390\/ijms24087076","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10333_CR19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12967-019-1984-2","volume":"17","author":"CE Onesti","year":"2019","unstructured":"Onesti CE, Boemer F, Josse C et al (2019) Tryptophan catabolism increases in breast cancer patients compared to healthy controls without affecting the cancer outcome or response to chemotherapy. J Transl Med 17(1):239. https:\/\/doi.org\/10.1186\/s12967-019-1984-2","journal-title":"J Transl Med"},{"key":"10333_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.807271","author":"F Peyraud","year":"2022","unstructured":"Peyraud F, Guegan J-P, Bodet D et al (2022) Targeting tryptophan catabolism in cancer immunotherapy era: challenges and perspectives. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.807271","journal-title":"Front Immunol"},{"issue":"5","key":"10333_CR21","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","volume":"18","author":"M Platten","year":"2019","unstructured":"Platten M, Nollen EAA, R\u00f6hrig UF et al (2019) Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat Rev Drug Discov 18(5):379\u2013401. https:\/\/doi.org\/10.1038\/s41573-019-0016-5","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"10333_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/bcr2607","volume":"12","author":"EA Rakha","year":"2010","unstructured":"Rakha EA, Reis-Filho JS, Baehner F et al (2010) Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast Cancer Res 12(4):207. https:\/\/doi.org\/10.1186\/bcr2607","journal-title":"Breast Cancer Res"},{"key":"10333_CR23","doi-asserted-by":"publisher","first-page":"e2098","DOI":"10.32113\/wcrj_20219_2098","volume":"8","author":"T Salmi","year":"2021","unstructured":"Salmi T, Dali-Sahi M, Guermouche B et al (2021) Status of indoleamine-2,3-dioxygenase 1 in infiltrating ductal carcinoma of breast cancer: a new prognostic indicator for aggressive tumors. WCRJ 8:e2098. https:\/\/doi.org\/10.32113\/wcrj_20219_2098","journal-title":"WCRJ"},{"issue":"15","key":"10333_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3390\/metabo14050247","volume":"14","author":"EA Sarf","year":"2024","unstructured":"Sarf EA, Dyachenko EI, Bel\u2019skaya LV (2024a) Salivary tryptophan as a metabolic marker of HER2-negative molecular subtypes of breast cancer. Metabolites 14(15):247. https:\/\/doi.org\/10.3390\/metabo14050247","journal-title":"Metabolites"},{"issue":"5","key":"10333_CR25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3390\/metabo14050247","volume":"14","author":"EA Sarf","year":"2024","unstructured":"Sarf EA, Dyachenko EI, Bel\u2019skaya LV et al (2024b) Salivary tryptophan as a metabolic marker of HER2-negative molecular subtypes of breast cancer. Metabolites 14(5):247. https:\/\/doi.org\/10.3390\/metabo14050247","journal-title":"Metabolites"},{"key":"10333_CR26","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1038\/modpathol.2010.33","volume":"2","author":"SJ Schnitt","year":"2010","unstructured":"Schnitt SJ (2010) Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy. Modern Pathol Suppl 2:S60\u2013S64. https:\/\/doi.org\/10.1038\/modpathol.2010.33","journal-title":"Modern Pathol Suppl"},{"issue":"32","key":"10333_CR27","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1038\/onc.2014.349","volume":"34","author":"MY Sherman","year":"2015","unstructured":"Sherman MY, Gabai VL (2015) Hsp70 in cancer: back to the future. Oncogene 34(32):4153\u20134161. https:\/\/doi.org\/10.1038\/onc.2014.349","journal-title":"Oncogene"},{"issue":"4","key":"10333_CR28","doi-asserted-by":"publisher","first-page":"496","DOI":"10.20892\/j.issn.2095-3941.2016.0066","volume":"13","author":"NA Soliman","year":"2016","unstructured":"Soliman NA, Yussif SM (2016) Ki-67 as a prognostic marker according to breast cancer molecular subtype. Cancer Biol Med 13(4):496\u2013504. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2016.0066","journal-title":"Cancer Biol Med"},{"issue":"5","key":"10333_CR29","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00262-013-1393-y","volume":"62","author":"H Soliman","year":"2013","unstructured":"Soliman H, Rawal B, Fulp J et al (2013) Analysis of indoleamine 2\u20133 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry. Cancer Immunol Immunother 62(5):829\u2013837. https:\/\/doi.org\/10.1007\/s00262-013-1393-y","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"10333_CR30","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/s13058-014-0415-9","volume":"16","author":"X Tang","year":"2014","unstructured":"Tang X, Lin CC, Spasojevic I et al (2014) A joint analysis of metabolomics and genetics of breast cancer. Breast Cancer Res 16(4):415. https:\/\/doi.org\/10.1186\/s13058-014-0415-9","journal-title":"Breast Cancer Res"},{"key":"10333_CR31","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1038\/s41467-024-47868-3","volume":"15","author":"N Venkateswaran","year":"2024","unstructured":"Venkateswaran N, Garcia R, Lafita-Navarro MC et al (2024) Tryptophan fuels MYC-dependent liver tumorigenesis through indole 3-pyruvate synthesis. Nat Commun 15:4266. https:\/\/doi.org\/10.1038\/s41467-024-47868-3","journal-title":"Nat Commun"},{"issue":"3","key":"10333_CR32","first-page":"85","volume":"11","author":"B Zakmout-Belaggoune","year":"2017","unstructured":"Zakmout-Belaggoune B, Addou-Klouche L, Bendaoud A et al (2017) Dermal lymphatic emboli (DLE) and Ki-67 biomarker in algerian inflammatory breast cancer patients. J Int Res Med Pharm Sci 11(3):85\u201391","journal-title":"J Int Res Med Pharm Sci"},{"issue":"1","key":"10333_CR33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao H et al (2021) Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther 6(1):263. https:\/\/doi.org\/10.1038\/s41392-021-00658-5","journal-title":"Signal Transduct Target Ther"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-024-10333-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-024-10333-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-024-10333-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T02:28:58Z","timestamp":1738808938000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-024-10333-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,21]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10333"],"URL":"https:\/\/doi.org\/10.1007\/s10735-024-10333-y","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,21]]},"assertion":[{"value":"20 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No potential conflict of interest was reported by the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethics Committee of the University of Tlemcen, Algeria.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that this report does not contain any personal information that could lead to patients\u2019 identification.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent and patient details"}}],"article-number":"52"}}